Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats

Published:2017-04-10 Issue:20 Volume:8 Page:33807-33826
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Na¹,Xu Liuqing¹,Shi Yingfeng¹,Fang Lu¹,Gu Hongwei¹,Wang Hongrui¹,Ding Xiaoqiang²,Zhuang Shougang¹³

Affiliation:

1. Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China

2. Division of Nephrology, Zhongshan Hospital, Fudan University, Shanghai 200032, China

3. Department of Medicine, Rhode Island Hospital and Brown University School of Medicine, Providence, RI 02903, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simiao pills alleviates renal injury associated with hyperuricemia: A multi-omics analysis;Journal of Ethnopharmacology;2024-10

2. The Terminalia chebula Retz extract treats hyperuricemic nephropathy by inhibiting TLR4/MyD88/NF-κB axis;Journal of Ethnopharmacology;2024-03

3. Network pharmacology, molecular docking, combined with experimental verification to explore the role and mechanism of shizhifang decoction in the treatment of hyperuricemia;Heliyon;2024-02

4. The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications;Frontiers in Immunology;2023-11-20

5. Renal Organic Anion Transporters 1 and 3 In Vitro: Gone but Not Forgotten;International Journal of Molecular Sciences;2023-10-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3